These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1496646)

  • 21. T-cell depletion and allogeneic bone marrow transplantation.
    O'Reilly RJ
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
    Champlin R
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute renal failure secondary to hepatic veno-occlusive disease in a bone marrow transplant patient].
    Borrego FJ; Viedma G; Pérez del Barrio P; Gil JM; de Santis-Scoccia C; Ramírez Huerta JM; Alcalá A; Pérez Bañasco V
    Nefrologia; 2003; 23(4):350-4. PubMed ID: 14558335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
    Kapoor N; Copelan EA; Klein J; Tutschka PJ
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():153-5. PubMed ID: 2697430
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatic complications of bone marrow transplantation].
    Martí Carvajal A
    G E N; 1991; 45(4):329-34. PubMed ID: 1843969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy.
    Vaughan WP; Dennison JD; Reed EC; Klassen L; McGuire TR; Sanger WG; Kumar PP; Warkentin PI; Gordon BG; Bierman PJ
    Bone Marrow Transplant; 1991 Dec; 8(6):489-95. PubMed ID: 1790429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
    Storb R; Appelbaum F; Buckner CD; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():80-4. PubMed ID: 2117976
    [No Abstract]   [Full Text] [Related]  

  • 30. [Whole body irradiation in the conditioning of bone marrow transplantation. Current indications and limiting factors].
    Ganem G; Cosset JM; Le Bourgeois JP
    Ann Med Interne (Paris); 1989; 140(5):387-92. PubMed ID: 2688510
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fulminant hepatitis-like veno-occlusive disease of the liver after allogeneic bone marrow transplantation in acute lymphoblastic leukemia].
    Naito H; Arioka H; Kobayashi R; Ishikawa Y
    Rinsho Ketsueki; 1993 May; 34(5):656-61. PubMed ID: 8315837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cure after allogeneic bone marrow transplantation: chemo-radiotherapy and/or graft-versus-leukemia?
    Hagenbeek A; Martens AC; Schultz FW; van Bekkum DW
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():91-3. PubMed ID: 2390645
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
    Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH
    Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone marrow transplantation for therapy of leukemia].
    Masaoka T
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1060-4. PubMed ID: 1383366
    [No Abstract]   [Full Text] [Related]  

  • 35. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
    Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graft versus host disease prophylaxis today.
    Martelli MF; Aversa F
    Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
    [No Abstract]   [Full Text] [Related]  

  • 40. Allogeneic bone marrow transplantation for multiple myeloma.
    Ballester OF
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):67-71. PubMed ID: 8211218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.